ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1380	National Cancer Institute	Html	en	Colorectal Cancer Prevention (PDQ®)–Health Professional Version	Expert-reviewed information summary about factors that may influence the risk of developing colorectal cancer and about research aimed at the prevention of this disease.	colon cancer death 0.503164 colorectal adenoma chemoprevention 0.469587 mg/day ASA group 0.474963 Engl J Med 0.695761 colorectal cancer risk 0.569497 American Cancer Society 0.478754 cancer prevention study 0.51311 Br J Cancer 0.490702 case-control study 0.528084 CRC mortality rates 0.469166 Ann Intern Med 0.669327 Int J Cancer 0.468816 colorectal cancer 0.947004 fatal colorectal cancer 0.499741 advanced colorectal adenomas 0.4802 colon cancer prevention 0.492834 CRC incidence 0.472239 Natl Cancer Inst 0.758173 human colon cancer 0.480578 hereditary nonpolyposis colorectal 0.489202 distal colon cancer 0.492725 colorectal adenomatous polyps 0.518043 colorectal adenoma prevention 0.476577 long-term cancer incidence 0.468066 familial adenomatous polyposis 0.503867	et al. 0.597227 familial colorectal cancer 0.51297 large bowel cancer 0.489321 colorectal adenomas 0.590599 previous colorectal cancer 0.507755 nonpolyposis colorectal cancer 0.531539 cohort study 0.504026 Cancer Epidemiol Biomarkers 0.584507 hereditary colon cancer 0.485595 fatal colon cancer 0.501384 PUBMED Abstract 0.577579 CRC mortality 0.486759 Health Study 0.488018 National Cancer Institute 0.488273 Epidemiol Biomarkers Prev 0.558059 colorectal cancer incidence 0.562507 colorectal cancer disparities 0.516267 common colorectal cancer 0.511542 colorectal cancer rates 0.517039 colon cancer 0.785918 Abstract 0.678628 colon cancer risk 0.507338 in-trial cancer deaths 0.471053 colorectal cancer mortality 0.563581	CLICK HERE
1475	National Cancer Institute	Html	en	Adult Primary Liver Cancer Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of adult primary liver cancer.	HCC tumors 0.58507 Semin Liver Dis 0.618193 Hepatocellular carcinoma incidence 0.684284 PDQ cancer information 0.577886 American Cancer Society 0.586704 early hepatocellular carcinoma 0.666995 primary biliary cirrhosis 0.576504 chronic liver disease 0.578131 unresectable hepatocellular carcinoma 0.664574 blood flow 0.562662 hepatocellular carcinoma 0.977206 primary liver cancer 0.589429 Natural history 0.564684 cancer information summary 0.576375 risk factors 0.586296 normal liver parenchyma 0.570598 liver disease 0.607293 liver 0.658374 virus-related hepatocellular carcinoma 0.677568 western European patients 0.565566 patients 0.658086 HCC 0.686159 advanced-stage HCC 0.594418 small hepatocellular carcinoma 0.692383 HCC patients 0.615983	HCC worldwide 0.602122 single hepatocellular carcinoma 0.672174 Liver Italian Program 0.573612 early HCC 0.59445 entire liver 0.564284 Liver Diseases 0.560344 Gastroenterol Hepatol 0.566445 AASLD hepatocellular carcinoma 0.670773 untreated hepatocellular carcinoma 0.669362 study 0.562576 HCC detection 0.593776 liver function 0.561177 PUBMED Abstract 0.598546 early-stage HCC 0.580393 class A cirrhosis 0.563518 arterial blood 0.606167 liver transplant 0.559717 cirrhosis 0.620285 hepatitis b virus 0.59513 Abstract 0.629123 cirrhosis type B. 0.576124 Llovet JM 0.573361 cm hepatocellular carcinoma 0.677106 liver resection 0.566362	CLICK HERE
1666	National Cancer Institute	Html	en	Testicular Cancer Screening (PDQ®)–Patient Version	Expert-reviewed information summary about tests used to detect or screen for testicular cancer.	testicular self-exams 0.545422 ongoing clinical trials 0.499986 PDQ cancer information 0.758311 testicular cancer 0.955987 testicular germ cell 0.59857 testicular carcinoma 0.546926 NCI Web site 0.507088 testicular cancers 0.553122 clinical trials 0.669739 early detection 0.495849 germ cells 0.505641 cancer information summary 0.64569 clinical trial 0.511819 breast cancer prevention 0.524202 spermatic cord 0.49407 PDQ summaries 0.534816 cancer patients 0.49191 latest published information 0.509374 NCI’s PDQ 0.538459 cancer symptoms 0.51215 NCI PDQ cancer 0.620022 tests 0.527688 testicular cancer screening 0.701295 routine screening test 0.519043	PDQ Screening 0.553678 testicles 0.486139 screening tests 0.48752 Cancer Information Service 0.545478 common cancer 0.501504 male sex glands 0.496865 Prevention Editorial Board 0.56412 treatment clinical trials 0.501604 National Cancer Institute 0.653794 PDQ documents 0.525451 cancer doctors 0.485997 long coiled tube 0.493438 new treatment 0.506259 health professional version 0.485461 Cancer screening trials 0.571582 PDQ database 0.532773 Cancer Care page 0.527585 Testicular Cancer Treatment 0.685082 risk factor 0.499445 PDQ summary 0.654344 routine physical exam 0.576949 cancer information summaries 0.554625 health professional versions 0.489301 comprehensive cancer information 0.555761	CLICK HERE
1716	National Cancer Institute	Html	en	Human Papillomavirus (HPV) Vaccines	A fact sheet about human papillomavirus (HPV) vaccines for the prevention of infection with certain types of HPV, which is the major cause of cervical cancer.	transmitted HPV types 0.372301 HPV prophylactic vaccines 0.352103 anal HPV 0.291899 HPV transmission 0.315597 available HPV vaccine 0.365066 HPV types 0.787213 Disease Control 0.208664 HPV vaccination coverage 0.329587 HPV vaccination program 0.333099 bivalent HPV vaccination 0.335395 hpv vaccination 0.566558 cervical cancer 0.335142 high-risk HPV infections 0.38085 HPV surface components 0.326712 genital HPV infection 0.36709 available HPV vaccines 0.389305 persistent HPV 0.314117 high-risk hpv types 0.523029 HPV vaccines 0.696012 human papillomavirus 0.38319 HPV vaccination series 0.361602 HPV infections 0.517426 genital HPV infections 0.379278 contact.  HPV infections 0.352636 human papillomavirus vaccine 0.256852	hpv infection 0.466234 current HPV vaccines 0.379891 women 0.226009 United States 0.375279 Updated HPV Vaccination 0.330423 current HPV infections 0.328908 therapeutic HPV vaccines 0.356162 human papillomavirus vaccines 0.212379 HPV Vaccination Recommendations 0.367966 Yes. Because HPV 0.297056 dozen high-risk HPV 0.362742 HPV 0.924148 routine HPV vaccination 0.357555 genital warts 0.26905 quadrivalent HPV vaccine 0.329163 additional HPV types 0.3896 quadrivalent human papillomavirus 0.21339 HPV vaccine product 0.372857 additional high-risk HPV 0.343778 currently approved HPV 0.315107 high-risk HPV type 0.392493 Gardasil 0.309437 vaccine-targeted HPV types 0.33361 et al 0.409031	CLICK HERE
1858	National Cancer Institute	Html	es	Tratamiento del cáncer de glándulas salivales (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del cáncer de glándulas salivales.	salivary gland carcinoma 0.756611 salivary neoplasms 0.424559 estroma linfoide 0.413137 prognostic factors 0.41902 gland tumours 0.43032 Spiro RH 0.465562 Sin embargo 0.429856 advanced salivary 0.421758 Malignant parotid tumors 0.41189 minor salivary 0.423431 tumores benignos 0.597781 Salivary Gland Disease 0.423228 tumores malignos mixtos 0.484605 botulinum toxin 0.428989 Radiat Oncol Biol 0.471433 glándulas salivales benignos 0.570833 neck neoplasia following 0.437258 fuerte predilección 0.414088 Parotid gland tumours 0.420714 salivary gland 0.859636 Head Neck Surg 0.476609 mucoepidermoid carcinoma 0.597885 gland malignant neoplasms 0.445484 tumores benignos mixtos 0.438326 único síntoma 0.425265	parotid gland 0.431427 lesiones carcinoma 0.466113 relativa frecuencia 0.450675 sección carcinoma 0.486375 carcinoma ex-tumor 0.470245 unresectable carcinomas 0.426636 Oral Oncol 0.420027 major salivary glands 0.414421 Otolaryngol Head Neck 0.413034 término carcinoma 0.475993 carcinoma epidermoide 0.472012 edad promedio 0.670934 Salivary Gland Tumours 0.424182 carcinoma with 0.481329 adenocarcinoma sai 0.463524 carcinoma salival basaloide 0.481935 carcinomas quísticos adenoides 0.459095 Botulinum toxin treatment 0.413697 with parotid carcinoma 0.483397 Oncol Biol Phys 0.47266 linfadenoma sebáceo 0.417003 elemento carcinoma 0.475416 carcinoma mucoepidermoide 0.988653 neoplasias benignas 0.45166	CLICK HERE
3551	National Cancer Institute	Html	en	Cancer Statistics	Basic information about cancer statistics in the U.S. and how they are used to understand the impact of cancer on society and to develop strategies that address the challenges that cancer poses.	cancer statistics 0.699332 major impact 0.569457 new screening test 0.610486 United States 0.848591 Asian/Pacific Islander women 0.623563 cancer death rate 0.734611 cancer deaths 0.662668 thyroid cancer 0.618391 SEER program website 0.613262 renal pelvis cancer 0.675159 population-based cancer registries 0.661094 African American men 0.620993 number 0.579668 new cancer cases 0.74726 American Cancer Society 0.655347 pancreatic cancer 0.619919 bladder cancer 0.619451 cancer-related deaths 0.575865 average age 0.568157 individual cancer types 0.652597 North American Association 0.605716 racial/ethnic group 0.570832 cancer care 0.615369 cancer diagnosis 0.664799	breast cancer 0.617639 rectum cancer 0.622513 large groups 0.569141 risk factor 0.614571 U.S. population 0.610565 people 0.571698 statistical trends 0.613522 age-adjusted mortality 0.572947 prostate cancer 0.619132 bronchus cancer 0.62075 Central Cancer Registries 0.654709 cancer survivors 0.603772 cancer mortality 0.652323 policy makers 0.566593 Understanding Cancer Prognosis 0.676403 endometrial cancer 0.620993 cancer 0.951216 new cases 0.679157 cancer incidence 0.694185 cancer death rates 0.665983 SEER Cancer Statistics 0.665479 overall cancer death 0.735155 cancer rates 0.609223	CLICK HERE
4300	National Cancer Institute	Html	en	Cancer Moonshot℠ Blue Ribbon Panel	The Blue Ribbon Panel Report outlines 10 recommendations to accelerate progress against cancer. The panel was established to ensure that the Cancer Moonshot's approaches are grounded in the best science.	BRP 0.544911 National Cancer Advisory 0.917882 pediatric cancer 0.537601 relevant scientific sectors 0.512578 Reduce cancer risk 0.54942 dynamic 3D maps 0.479491 early detection 0.494934 therapeutic targets 0.493364 presidentially appointed National 0.528792 new preclinical models 0.493659 national cancer data 0.584851 previously effective treatments 0.485016 early detection strategies 0.482919 new therapeutic targets 0.480719 cancer resistance 0.471789 E. Intensify research 0.49241 translational science network 0.495254 cancer technologies 0.513048 public idea submission 0.473834 broader cancer community 0.579774 transformative research recommendations 0.554836 cancer immunotherapy network 0.593107 Ribbon Panel report 0.661804 tumor evolution 0.579883	cancer health disparities 0.557334 final recommendations 0.465114 Cancer Immunology 0.464811 human tumor evolution 0.504864 specific recommendations 0.466439 cancer prevention 0.548373 C. Develop ways 0.499508 tumor profile data 0.530939 cancer cells 0.472187 group members 0.429792 Minimize cancer treatment 0.561924 direct patient involvement 0.494413 joint recommendations 0.465939 3D cancer atlas 0.546232 multiple groups 0.44011 Cancer Moonshot Task 0.60025 Blue Ribbon Panel 0.890429 groups 0.493987 BRP members 0.537843 major topic areas 0.508582 Cancer Advisory Board 0.925259 efficient data analysis 0.49446 Develop new cancer 0.562862 future patient outcomes 0.484191	CLICK HERE
15882	National Cancer Institute	Html	es	Cardo mariano (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos sobre el uso del cardo mariano como tratamiento para personas con cáncer.	Silybum marianum 0.735385 Agarwal R 0.945743 cell lines 0.375003 cell growth 0.494513 prostate carcinoma du145 0.373715 DNA synthesis 0.442196 carcinoma cell 0.46955 silybum marianum l 0.361146 Inhibitory effect 0.390679 Agarwal C 0.386743 receptor modulator activity 0.356592 Mol Carcinog 0.378538 Cancer Res 0.59348 carcinoma cell growth 0.407562 prostate carcinoma cells 0.4865 Singh RP 0.367955 flavonoid antioxidant 0.678831 active constituent 0.382485 Antiproliferative effect 0.363827 lipid peroxidation 0.585387 Biochem Pharmacol 0.461277 chemopreventive effects 0.369648 cardo lechero 0.365629 patients with 0.374862 cell growth inhibition 0.393232	Sonnenbichler J 0.428511 prostate carcinoma 0.590474 Campos R 0.414926 Pharmacol Res 0.429959 protective effects 0.379153 Biophys Res Commun 0.50103 prostate-specific antigen with 0.369145 carcinoma du145 cells 0.397873 Biochem Biophys Res 0.508991 Silymarin effects 0.38621 Biomed Res Int 0.385769 Clin Biol Res 0.375557 insulin-like growth factor-binding 0.358425 stimulatory effects 0.357205 Zhao J 0.53049 Guerra R 0.490633 with cell growth 0.41107 comparison with 0.378495 silibinin inhibits 0.378656 Planta Med 0.529049 protects against 0.371646 Mutat Res 0.369799 from silybum marianum 0.396284 Res Commun 0.505421	CLICK HERE
16049	National Cancer Institute	Html	en	Managing Costs and Medical Information	People with cancer may face major financial challenges and need help dealing with the high costs of care. Cancer treatment can be very expensive, even when you have insurance. Learn ways to manage medical information, paperwork, bills, and other records.	cancer treatment 0.452926 file folder 0.451204 emergency room 0.448618 medical bills 0.53618 state specific information 0.467913 insurance coverage 0.460494 health care team 0.51276 American Cancer Society 0.460319 payment options 0.46621 non-medical phone calls 0.432178 social worker 0.59281 clinical trials 0.467219 health care providers 0.479775 State Health Insurance 0.507522 cancer care 0.486022 research costs 0.450096 Track daily events 0.441284 Insurance Assistance Service 0.484543 health care costs 0.531061 patient care costs 0.553498 travel costs 0.463012 government health insurance 0.504906 treatment 0.485685 electronic medical record 0.447232 health care bills 0.536309	insurance company pay 0.509196 help finding referrals 0.489042 Cancer Information Service 0.588627 financial issues 0.432149 Health Insurance Assistance 0.617568 special email account 0.433974 sample chart 0.453844 discount drug programs 0.446076 separate folder 0.500544 extra costs 0.480459 bills 0.574419 hospital 0.455427 health care 0.679621 key medical information 0.460671 insurance company 0.914855 costs 0.714673 NCI Cancer Information 0.458766 important medical information 0.475214 human resources department 0.455264 medicine 0.454681 health care coverage 0.489272 insurance companies 0.472181 doctor 0.602384 mobile device 0.452113	CLICK HERE
17294	National Cancer Institute	Html	es	Anemia	Información y consejos para controlar la anemia, un efecto secundario del tratamiento del cáncer.	suficientes glóbulos 0.941582		CLICK HERE